This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,177.00 firm-fixed-price delivery order contract is for the supply of INFED 100 MG/2 ML VIAL 2ML, a medical product, with a performance period through September 12, 2024. The contract is not set aside and allows for the delivery of a range of pharmaceutical and medical products to support military and federal...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,000.10, is a delivery order to provide 4567632634 ! INFED 100 MG/2 ML VIAL 2ML medical supplies. The contract has a firm fixed price pricing type and a period of performance through March 20, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a $2,876.54 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of 4567893692 INFED 100 MG/2 ML VIAL 2ML and has an ultimate completion date of April 14, 2025. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The $8,901.48 Firm Fixed Price Delivery Order is for the supply of INFED 100 MG/2 ML VIAL 2ML, a pharmaceutical product. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and...
This federal contract award, valued at $7,608.71, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for INFED 100 MG/2 ML VIAL 2ML, a medical product, with a Firm Fixed Price pricing type and an ultimate completion date of June 21, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, with a ceiling value of $3,400.46, is for the provision of INFED 100 MG/2 ML VIAL 2ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $17,825.97, is for the delivery of medical supplies, specifically 4567741438 ! INFED 100MG/2ML VI 10S. The contract has an ultimate completion date of April 25, 2025 and was awarded on March 31, 2025. It is a Firm Fixed Price Delivery Order contract, with no set-aside...
This federal contract award is for the delivery of INFED 100 MG/2 ML VIAL 2ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,970.10 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract has a performance period through January 26, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of INFED 100 MG/2 ML VIAL 2ML pharmaceutical products. The total ceiling value of the contract is $8,055.27, and the ultimate completion date is April 16, 2024. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor for this award. The contract does not have a...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $2,612.40 contract is for the delivery of INFED 100 MG/2 ML VIAL 2ML, a pharmaceutical product, with a completion date of January 24, 2024. Amerisourcebergen Drug Corp has previously received numerous federal contracts from DLA Troop Support Medical to supply pharmaceuticals,...